|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07D 471/04 | (2013.01) |
| (11) | Patento numeris | 3753938 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20169634.1 |
| Europos patento paraiškos padavimo data | 2018-02-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-12-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201762460677 P | 2017-02-17 | US | |
| 201762490881 P | 2017-04-27 | US | |
| 201762573991 P | 2017-10-18 | US |
| (72) |
GLICK, Gary , US
GHOSH, Shomir , US
ROUSH, William R. , US
OLHAVA, Edward James , US
O'MALLEY, Daniel , US
|
| (73) |
Innate Tumor Immunity, Inc. ,
Route 206 and Province Line Road, Princeton, New Jersey 08543,
US
|
| (54) | SUBSTUTUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS |
| SUBSTUTUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS |